A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis

Abstract

Continuous subcutaneous terbutaline infusion is an exciting new development in treatment of preterm labor. Its use is associated with a significant, albeit transitory, increase in glucose intolerance. This effect may be of little significance for the pregnant woman with normal glucose tolerance. For the woman with impaired glucose tolerance, gestational diabetes, or preexisting insulin-dependent diabetes, subcutaneous terbutaline may cause severe metabolic decompensation with hyperglycemia and ketoacidosis. Careful monitoring of plasma glucose and urine ketones is necessary August 1990 Am J Obstet Gynecol